awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33884913-247F09A8-866C-4E61-B99A-C2B74DCFAA37
Q33884913-247F09A8-866C-4E61-B99A-C2B74DCFAA37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33884913-247F09A8-866C-4E61-B99A-C2B74DCFAA37
Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years.
P2860
Q33884913-247F09A8-866C-4E61-B99A-C2B74DCFAA37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33884913-247F09A8-866C-4E61-B99A-C2B74DCFAA37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1e5ad00c6c0caf71a3c2e5fc97f46bb53691e62
P2860
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.